Factors and Indicators Affecting Past and Projected Sales in the Ovarian Cancer Industry.Many factors and indicators exist that influence the past and projected sales in all service industries.
Many factors and indicators exist that influence the past and projected sales in all service industries. Most of these factors are the same irrespective of the different and diverse services offered in the current market. The medical industry is one of them since it offers services to the people. Specifically, this paper deals with factors and indicators that affect the past and projected sales of ovarian cancer services. Just like any other service, several factors affect its sales such as technology, government policies, economy of the country, social demographics and the industry leaders. Ovarian cancer has been recognized as the most lethal gynecologic cancer. The following diagram shows the death rate of all races in United States since 1999 70 2009. It is takes up 3% of cancer in women (Ovarian Cancer National Alliance 2010).
Factors Affecting Sales of Ovarian Cancer Services
Ovarian cancer is the type of cancer that affects women in the ovaries. It is estimated that ovarian cancer affects about 20,000 women every year in the United States. In 2009, 20,460 women were diagnosed with ovarian cancer and 14,436 died out of it in the same year. It is also ranked the fifth leading death cancer after several others in women. Just like other services, ovarian cancer cervices are influenced by several factors. The first one is technology that affects all services. When there is better technology for screening of ovarian cancer, many people will want to go for the test due to the importance of having it. However, if the technology is expensive, it will discourage many people from going for the screening.
One of the technologies that are likely to increase sale of ovarian cancer services is nanotechnology, which researchers ascertain that it has the ability to kill the cancerous cells without eliciting the side effects seen in chemotherapy such as loosing hair. With such technology, patients will be encouraged to use it since it reduces other side effects and is far more effective and safer as opposed to the other technologies. On the other hand, ovarian cancer is not very popular and its screening methods have not been effective. The technology used such as conducting blood test for a cancer marker known as antigen-125 or the use of trans-viginal ultrasonography on healthy women. Many of the women put in further testing after signs of ovarian cancer using this methods end up not having the cancer. Further testing includes surgery, which leaves other side effects. Therefore, such technology affects sales negatively since health groups have recommended against it based on reasons that it does not reduce ovarian cancer deaths and causes harm to patients after further screening. Thus, it is not effective and discourages sales of ovarian cancer services.